Результати пошуку - Juby A. Jacob‐Nara

  • Показ 1 - 17 результатів із 17
Уточнити результати
  1. 1
    The interleukin-4/interleukin-13 pathway in type 2 inflammation in chronic rhinosinusitis with nasal polyps

    The interleukin-4/interleukin-13 pathway in type 2 inflammation in chronic rhinosinusitis with nasal polyps за авторством Claus Bachert, Alexandra Hicks, Simon Gane, Anju T. Peters, Philippe Gevaert, Scott D. Nash, Julie Horowitz, Harry Sacks, Juby A. Jacob‐Nara

    Опубліковано 2024
    Отримати повний текст Отримати повний текст
    Revisão
    Додати у Вибране
    Збережено в:
  2. 2
    Dupilumab efficacy in patients with chronic rhinosinusitis with nasal polyps with and without allergic rhinitis

    Dupilumab efficacy in patients with chronic rhinosinusitis with nasal polyps with and without allergic rhinitis за авторством Anju T. Peters, Martin Wagenmann, Jonathan A. Bernstein, Asif Khan, Scott D. Nash, Juby A. Jacob‐Nara, Shahid Siddiqui, Paul J. Rowe, Yamo Deniz

    Опубліковано 2023
    Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  3. 3
    Type 2 Inflammation and Asthma in Children: A Narrative Review

    Type 2 Inflammation and Asthma in Children: A Narrative Review за авторством Nikolaos G. Papadopoulos, Leonard B Bacharier, Daniel J Jackson, A. Deschildre, Wanda Phipatanakul, Stanley J Szefler, Rebecca Gall, Olivier Ledanois, Juby A Jacob-Nara, Harry Sacks

    Опубліковано 2024
    Отримати повний текст
    Revisão
    Додати у Вибране
    Збережено в:
  4. 4
    Disease Burden and Unmet Need in Eosinophilic Esophagitis

    Disease Burden and Unmet Need in Eosinophilic Esophagitis за авторством Albert J. Bredenoord, Kiran Patel, Alain Schoepfer, Evan S. Dellon, Mirna Chehade, Seema S. Aceves, Jonathan M. Spergel, Brad Shumel, Yamo Deniz, Paul J. Rowe, Juby A. Jacob‐Nara

    Опубліковано 2022
    Отримати повний текст
    Revisão
    Додати у Вибране
    Збережено в:
  5. 5
    Prevalence of type 2 inflammatory signatures and efficacy of dupilumab in patients with chronic rhinosinusitis with nasal polyps from two phase 3 clinical trials: SINUS‐24 and SINUS‐52

    Prevalence of type 2 inflammatory signatures and efficacy of dupilumab in patients with chronic rhinosinusitis with nasal polyps from two phase 3 clinical trials: SINUS‐24 and SINU... за авторством Claus Bachert, Asif Khan, Stella E. Lee, Claire Hopkins, Anju T. Peters, Wytske J. Fokkens, Amy Praestgaard, Amr Radwan, Scott D. Nash, Juby A. Jacob‐Nara, Yamo Deniz, Paul J. Rowe

    Опубліковано 2023
    Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  6. 6
    Dupilumab Efficacy in Children With Type 2 Asthma Receiving High- to Medium-Dose Inhaled Corticosteroids (VOYAGE)

    Dupilumab Efficacy in Children With Type 2 Asthma Receiving High- to Medium-Dose Inhaled Corticosteroids (VOYAGE) за авторством Jorge Máspero, Martti Antila, A. Deschildre, Leonard B. Bacharier, Arman Altincatal, Elizabeth Laws, Eric Mortensen, Amr Radwan, Juby A. Jacob‐Nara, Yamo Deniz, Paul J. Rowe, David J. Lederer, Megan Hardin

    Опубліковано 2024
    Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  7. 7
    Dupilumab leads to better-controlled asthma and quality of life in children: the VOYAGE study

    Dupilumab leads to better-controlled asthma and quality of life in children: the VOYAGE study за авторством Alessandro Fiocchi, Wanda Phipatanakul, Robert S. Zeiger, Sandy Durrani, Jeremy Cole, Jérôme Msihid, Rebecca Gall, Juby A. Jacob‐Nara, Yamo Deniz, Paul J. Rowe, David J. Lederer, Megan Hardin, Yi Zhang, Asif Khan

    Опубліковано 2023
    Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  8. 8
    Dupilumab efficacy in subgroups of type 2 asthma with high-dose inhaled corticosteroids at baseline

    Dupilumab efficacy in subgroups of type 2 asthma with high-dose inhaled corticosteroids at baseline за авторством Arnaud Bourdin, J. Christian Virchow, Alberto Papi, Njira Lugogo, Philip G. Bardin, Martti Antila, David Halpin, Nadia Daizadeh, Michel Djandji, Benjamin Ortiz, Juby A. Jacob‐Nara, Rebecca Gall, Yamo Deniz, Paul J. Rowe

    Опубліковано 2022
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  9. 9
    Dupilumab efficacy and safety in Latin American patients with uncontrolled, moderate-to-severe asthma: phase 3 LIBERTY ASTHMA QUEST study

    Dupilumab efficacy and safety in Latin American patients with uncontrolled, moderate-to-severe asthma: phase 3 LIBERTY ASTHMA QUEST study за авторством Jorge Máspero, Guido Cardona, Patricia Schonffeldt, Alberto Tolcachier, Sandra Nora González Díaz, Anahí Yáñez, Clóvis Eduardo Santos Galvão, Jérôme Msihid, Rebecca Gall, Shahid Siddiqui, Paul J. Rowe, Yamo Deniz, Juby A. Jacob‐Nara, Michel Djandji

    Опубліковано 2022
    Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  10. 10
    Dupilumab Improves Lung Function Parameters in Pediatric Type 2 Asthma: VOYAGE Study

    Dupilumab Improves Lung Function Parameters in Pediatric Type 2 Asthma: VOYAGE Study за авторством Leonard B. Bacharier, Theresa W. Guilbert, Constance H. Katelaris, A. Deschildre, Wanda Phipatanakul, Dongfang Liu, Arman Altincatal, Leda Mannent, Nikhil Amin, Elizabeth Laws, Bolanle Akinlade, Juby A. Jacob‐Nara, Yamo Deniz, Paul J. Rowe, David J. Lederer, Megan Hardin

    Опубліковано 2023
    Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  11. 11
    Assessment of dupilumab in children with moderate‐to‐severe type 2 asthma with or without evidence of allergic asthma

    Assessment of dupilumab in children with moderate‐to‐severe type 2 asthma with or without evidence of allergic asthma за авторством Nikolaos G. Papadopoulos, Stanley J. Szefler, Leonard B. Bacharier, Jorge Máspero, Christian Domingo, Alessandro Fiocchi, Jason K. Lee, Nadia Daizadeh, David J. Lederer, Megan Hardin, Rebecca Gall, Michel Djandji, Shahid Siddiqui, Juby A. Jacob‐Nara, Yamo Deniz, Paul J. Rowe

    Опубліковано 2023
    Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  12. 12
    Preclinical and clinical experience with dupilumab on the correlates of live attenuated vaccines

    Preclinical and clinical experience with dupilumab on the correlates of live attenuated vaccines за авторством Michael E. Wechsler, Adelmir Souza‐Machado, Christine Xu, Xuezhou Mao, Upender Kapoor, Faisal A. Khokhar, John T. O’Malley, Christopher D. Petro, Veronica Mas Casullo, Leda Mannent, Paul J. Rowe, Juby A. Jacob‐Nara, Marcella Ruddy, Elizabeth Laws, Lisa A. Purcell, Megan Hardin

    Опубліковано 2021
    Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  13. 13
    Effect of Dupilumab on Blood Eosinophil Counts in Patients With Asthma, Chronic Rhinosinusitis With Nasal Polyps, Atopic Dermatitis, or Eosinophilic Esophagitis

    Effect of Dupilumab on Blood Eosinophil Counts in Patients With Asthma, Chronic Rhinosinusitis With Nasal Polyps, Atopic Dermatitis, or Eosinophilic Esophagitis за авторством Michael E. Wechsler, Amy D. Klion, Pierluigi Paggiaro, Parameswaran Nair, D. Staumont‐Sallé, Amr Radwan, Robert R. Johnson, Upender Kapoor, Faisal A. Khokhar, Nadia Daizadeh, Zhen Chen, Elizabeth Laws, Benjamin Ortiz, Juby A. Jacob‐Nara, Leda Mannent, Paul J. Rowe, Yamo Deniz

    Опубліковано 2022
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  14. 14
    Dupilumab Induces Long-Term On-Treatment Clinical Remission in Patients With Type 2 Asthma

    Dupilumab Induces Long-Term On-Treatment Clinical Remission in Patients With Type 2 Asthma за авторством Ian Pavord, Klaus F. Rabe, Elliot Israel, Stanley J. Szefler, Guy Brusselle, Nami Pandit‐Abid, Arman Altincatal, Zhen Chen, Nikhil Amin, Asif Khan, David J. Lederer, Yi Zhang, Paul J. Rowe, Yamo Deniz, Amr Radwan, Juby A. Jacob‐Nara, William W. Busse

    Опубліковано 2024
    Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  15. 15
    Efficacy of dupilumab in patients with moderate-to-severe asthma and persistent airflow obstruction

    Efficacy of dupilumab in patients with moderate-to-severe asthma and persistent airflow obstruction за авторством Nicola A. Hanania, Mario Castro, Eric D. Bateman, Ian Pavord, Alberto Papi, J. Mark FitzGerald, Jorge Máspero, Constance H. Katelaris, Dave Singh, Nadia Daizadeh, Arman Altincatal, Nami Pandit‐Abid, Xavier Soler, Shahid Siddiqui, Elizabeth Laws, Juby A. Jacob‐Nara, Paul J. Rowe, David J. Lederer, Megan Hardin, Yamo Deniz

    Опубліковано 2022
    Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  16. 16
    Dupilumab pharmacokinetics and effect on type 2 biomarkers in children with moderate-to-severe asthma

    Dupilumab pharmacokinetics and effect on type 2 biomarkers in children with moderate-to-severe asthma за авторством Daniel J. Jackson, Leonard B. Bacharier, Wanda Phipatanakul, Lawrence Sher, Christian Domingo, Nikolaos G. Papadopoulos, Brian D. Modena, Ning Li, Changming Xia, Mohamed Kamal, Myles Dillon, Kelley Wolfe, Rebecca Gall, Nikhil Amin, Leda Mannent, Elizabeth Laws, Paul J. Rowe, Juby A. Jacob‐Nara, Yamo Deniz, David J. Lederer, Megan Hardin, Christine Xu

    Опубліковано 2023
    Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  17. 17
    Evaluating the Effect of Dupilumab on Type 2 Airway Inflammation and Mucus Plugging in Patients with Uncontrolled Moderate-To-Severe Asthma: the VESTIGE Trial

    Evaluating the Effect of Dupilumab on Type 2 Airway Inflammation and Mucus Plugging in Patients with Uncontrolled Moderate-To-Severe Asthma: the VESTIGE Trial за авторством Mario Castro, Alberto Papi, Celeste Porsbjerg, Njira Lugogo, Christopher E. Brightling, Francisco Javier González‐Barcala, Arnaud Bourdin, Мykola Ostrovskyy, Maria Staevska, P I Chou, Liliana Duca, Ana Pereria, Charles Fogarty, Rufai Nadama, Mei Zhang, Amelie Rodrigues, Xavier Soler, Simona Pantelimon, Harry Sacks, Yamo Deniz, Paul Rowe, Lucía De Prado Gómez, Juby A. Jacob‐Nara

    Опубліковано 2024
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:

Інструменти для пошуку: